Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy

Chantal Guillemette

Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)

All cancers but non-melanoma skin cancer

Peter Blumberg

Molecular Mechanism of Action of Phorbol Ester

All cancers but non-melanoma skin cancer

James Dennis

The role of Tudor domain proteins in normal development and cancer

All cancers but non-melanoma skin cancer

Laurence Pelletier

CRC Tier 1 - Understand how centrosome duplicate, grow and participate in the formation of mitotic spindles and cilia

All cancers but non-melanoma skin cancer

Pathology

Sarah Hughes

CRC Tier 2 - Understanding how Merlin acts as a tumour suppressor

All cancers but non-melanoma skin cancer

Jeffrey Rubin

Wnt Signaling and Secreted Frizzled-Related Proteins

All cancers but non-melanoma skin cancer

Dale Laird

Mechanisms underlying inherited human diseases and cancers in tissue-relevant models (CANADA RESEARCH CHAIRHOLDER)

All cancers but non-melanoma skin cancer

Abigail Rachele Mateo

C. elegans p53 family transcription factor has roles in meiotic recombination and DNA interstrand crosslink repair

All cancers but non-melanoma skin cancer

Denis C Guttridge

Second Cancer Cachexia Conference: Evolving Mechanisms and Therapies

All cancers but non-melanoma skin cancer